UB Paderborn / Katalog / Suche / in CDI

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

Clinical cancer research, 2016-08, Vol.22 (15), p.3764-3773

2016

Link zum Volltext

Verfügbarkeit prüfen

Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes

British journal of cancer, 2018-11, Vol.119 (11), p.1401-1409

2018

Link zum Volltext

Verfügbarkeit prüfen

Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort

Journal of clinical oncology, 2013-04, Vol.31 (11), p.1428-1434

2013

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy

International journal of radiation oncology, biology, physics, 2013-08, Vol.86 (5), p.848-853

2013

Link zum Volltext

Verfügbarkeit prüfen

External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis

PloS one, 2024-05, Vol.19 (5), p.e0296459-e0296459

2024

Link zum Volltext

Verfügbarkeit prüfen

Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3570-3576

2010

Link zum Volltext

Verfügbarkeit prüfen

Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis

Human genetics, 2007-09, Vol.122 (2), p.201-206

2007

Link zum Volltext

Verfügbarkeit prüfen

Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma

Clinical cancer research, 2013-11, Vol.19 (22), p.6261-6271

2013

Link zum Volltext

Verfügbarkeit prüfen

Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients

Arthritis research & therapy, 2020-12, Vol.22 (1), p.282-282, Article 282

2020

Link zum Volltext

Verfügbarkeit prüfen

Genetic Mapping in the Presence of Genotyping Errors

Genetics (Austin), 2007-08, Vol.176 (4), p.2521-2527

2007

Link zum Volltext

Verfügbarkeit prüfen

Validation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma

Journal of thoracic oncology, 2015-01, Vol.10 (1), p.67-73

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene

Human molecular genetics, 2008-07, Vol.17 (13), p.1938-1945

2008

Link zum Volltext

Verfügbarkeit prüfen

P063: A second-generation polygenic risk score (PRS) based on genetic ancestry improves breast cancer (BC) risk prediction for all ancestries

Genetics in Medicine Open, 2024, Vol.2, p.100945

2024

Link zum Volltext

Verfügbarkeit prüfen

Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation

Human molecular genetics, 2007-03, Vol.16 (6), p.579-591

2007

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide Association Scan Identifies a Prostaglandin-Endoperoxide Synthase 2 Variant Involved in Risk of Knee Osteoarthritis

American journal of human genetics, 2008-06, Vol.82 (6), p.1231-1240

2008

Link zum Volltext

Verfügbarkeit prüfen

P063: Prospective longitudinal validation of a breast cancer risk prediction model in a cohort of 130,058 individuals

Genetics in Medicine Open, 2023, Vol.1 (1), p.100082, Article 100082

2023

Link zum Volltext

Verfügbarkeit prüfen

Predicting absolute benefit in risk of metastasis of androgen deprivation therapy added to radiation therapy in patients with newly diagnosed prostate cancer using Prolaris

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5030-5030

2023

Link zum Volltext

Verfügbarkeit prüfen

A Major Predisposition Locus for Severe Obesity, at 4p15-p14

American journal of human genetics, 2002-06, Vol.70 (6), p.1459-1468

2002

Link zum Volltext

Verfügbarkeit prüfen

The genome of the domesticated apple ( Malus × domestica Borkh.)

Nature genetics, 2010-10, Vol.42 (10), p.833-839

2010

Link zum Volltext

Verfügbarkeit prüfen

Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes

Breast cancer research : BCR, 2014-01, Vol.16 (6), p.475-475

2014

Link zum Volltext

Verfügbarkeit prüfen

Rates of homologous recombination deficiency across different subtypes of ovarian cancer and in pre- and post-neoadjuvant chemotherapy tumor samples (139.5)

Gynecologic oncology, 2022-08, Vol.166, p.S86-S87

2022

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive multi-omic testing from a single laboratory to provide information in ovarian cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e15045-e15045

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of genomic instability test scores used for predicting PARP activity in ovarian cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1586-1586

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes

Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

Prognostic Utility of Cell Cycle Progression Score in Men With Prostate Cancer After Primary External Beam Radiation Therapy

External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis

Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer

Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis

Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma

Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients

Genetic Mapping in the Presence of Genotyping Errors

Validation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma

Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene

P063: A second-generation polygenic risk score (PRS) based on genetic ancestry improves breast cancer (BC) risk prediction for all ancestries

Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation

Genome-wide Association Scan Identifies a Prostaglandin-Endoperoxide Synthase 2 Variant Involved in Risk of Knee Osteoarthritis

P063: Prospective longitudinal validation of a breast cancer risk prediction model in a cohort of 130,058 individuals

Predicting absolute benefit in risk of metastasis of androgen deprivation therapy added to radiation therapy in patients with newly diagnosed prostate cancer using Prolaris

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

A Major Predisposition Locus for Severe Obesity, at 4p15-p14

The genome of the domesticated apple ( Malus × domestica Borkh.)

Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes

Rates of homologous recombination deficiency across different subtypes of ovarian cancer and in pre- and post-neoadjuvant chemotherapy tumor samples (139.5)

Comprehensive multi-omic testing from a single laboratory to provide information in ovarian cancer

Comparison of genomic instability test scores used for predicting PARP activity in ovarian cancer

Suchergebnisse filtern